| Cai, Long |
California Institute Of Technology
United States |
Understanding the role of tumor microenvironment in low grade glioma progression to malignancy |
1U01CA294551-01 |
|
Sidney Fu, M.D. |
| Cantuaria, Guilherme |
Northside Hospital Atlanta
United States |
Georgia NCI Community Oncology Research Program (GA NCORP) |
5UG1CA189997-11 |
|
Vanessa A. White, M.P.H. |
| Cao, Weidan |
Ohio State University
United States |
Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System |
1R01CA301579-01 |
|
Eileen Dimond, R.N., M.S. |
| Cao, Shugeng |
University Of Hawaii At Hilo
United States |
Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors |
5UG3CA290375-02 |
|
Altaf Mohammed, Ph.D. |
| Cao, Yin |
Washington University
United States |
PROSPECT-Global Consortium and Risk Factor Discovery |
1OT2CA297576-01 |
|
Asad Umar, D.V.M., Ph.D. |
| Carlson, Jay W |
Ozark Health Ventures, Llc
United States |
Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) |
5UG1CA189822-11 |
|
Vanessa A. White, M.P.H. |
| Carson, Tiffany Lashaun |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults |
5R01CA253219-05 |
|
Young Kim, Ph.D. |
| Castilla, Lucio H. |
Univ Of Massachusetts Med Sch Worcester
United States |
Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD |
1U01CA296350-01 |
|
Marjorie Perloff, M.D. |
| Castro, Cesar M |
Massachusetts General Hospital
United States |
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach |
5U01CA279858-02 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Caulin, Carlos |
University Of Arizona
United States |
Genetic Alterations That Confer High Risk to Oral Premalignant Lesions |
5R01CA274857-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
|
